Sanofi (SNY) Dividends Paid - Common (2009 - 2026)
Sanofi's (SNY) quarterly Dividends Paid - Common came in at $6.1 billion in Q2 2026, up 14.71% year-over-year from $5.3 billion in Q2 2025, and up 1746.04% quarter-over-quarter from -$370.0 million in Q1 2026.
Analysis
Sanofi (SNY) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Sanofi has disclosed Dividends Paid - Common across 18 years of filings, most recently posting $6.1 billion for Q2 2026.
- In Q2 2026, Dividends Paid - Common rose 14.71% year-over-year to $6.1 billion; the TTM figure through Jun 2026 stood at -$11.0 billion (down 130.45% YoY), while the FY2025 annual figure was $2.4 billion, down 53.72% from the prior year.
- Dividends Paid - Common came in at $6.1 billion for Q2 2026 at Sanofi, up from -$370.0 million in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $6.1 billion in Q2 2026 to a low of -$11.2 billion in Q3 2025.
- Average Dividends Paid - Common over 5 years is -$2.7 billion, with a median of -$4.8 billion recorded in 2023.
- The largest YoY upside for Dividends Paid - Common was 14.71% in 2026 against a maximum downside of 528.91% in 2026.
- Over 5 years, Dividends Paid - Common stood at -$4.3 billion in 2022, then retreated by 12.7% to -$4.8 billion in 2023, then declined by 4.89% to -$5.0 billion in 2024, then declined by 10.51% to -$5.6 billion in 2025, then soared by 209.63% to $6.1 billion in 2026.
- Per Business Quant data, the three most recent Dividends Paid - Common figures were $6.1 billion in Q2 2026, -$370.0 million in Q1 2026, and -$5.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -2.87 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 2.45 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 1.29 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 6.09 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.09 Bn |
| Mar 31, 2026 | -369.96 Mn |
| Dec 31, 2025 | -5.55 Bn |
| Sep 30, 2025 | -11.16 Bn |
| Jun 30, 2025 | 5.31 Bn |
| Mar 31, 2025 | 86.25 Mn |
| Dec 31, 2024 | -5.03 Bn |
| Sep 30, 2024 | -5.14 Bn |
| Dec 31, 2023 | -4.79 Bn |
| Sep 30, 2023 | -4.80 Bn |
| Dec 31, 2022 | -4.25 Bn |
| Dec 31, 2021 | -4.59 Bn |
| Dec 31, 2020 | -4.69 Bn |
| Dec 31, 2019 | -4.24 Bn |
| Dec 31, 2018 | -4.31 Bn |
| Dec 31, 2017 | -4.37 Bn |
| Dec 31, 2016 | -4.06 Bn |
| Dec 31, 2015 | -4.05 Bn |
| Dec 31, 2014 | -4.59 Bn |
| Dec 31, 2013 | 4.95 Bn |